Life Sciences Biz NanoString Gets OK For $393M Ch. 11 Sale

By Clara Geoghegan · April 19, 2024, 5:22 PM EDT

Insolvent biotech company NanoString can be sold to scientific instrument maker Bruker Corp., a Delaware bankruptcy judge ruled Friday, after the buyer clinched the winning bid during a 14-hour Chapter 11...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

NanoString Technologies, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

February 04, 2024

Recent Articles By Clara

March 25, 2024
Judge Probes If $54M Deal Will Affect Tehum Care Ch. 11 Plan
March 05, 2024
Rite Aid Process To Break Leases, Close Stores In Ch. 11 OK'd
February 14, 2024
Pharma Co. Humanigen Gets OK For Ch. 11 Sale
February 13, 2024
FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale
January 29, 2024
Shumaker Can't Get Double Fees For Appeal, Wilkes Says
January 25, 2024
Service Snag Delays Hospital Operator's Ch. 11 Confirmation
January 22, 2024
Medical Software Co. Eye Care Leaders OK'd For Joint Ch. 11
January 19, 2024
UpHealth's 'Full Pay' Ch. 11 Plan On Horizon, Committee Says
December 20, 2023
Biochemical Co. Amyris OK'd To Sell Celebrity Brands
December 20, 2023
Pharma Co. Impel Hits Ch. 11 With $127M Debt And Sale Plans